Literature DB >> 12604616

Sef inhibits fibroblast growth factor signaling by inhibiting FGFR1 tyrosine phosphorylation and subsequent ERK activation.

Dmitry Kovalenko1, Xuehui Yang, Robert J Nadeau, Lauren K Harkins, Robert Friesel.   

Abstract

Signaling through fibroblast growth factor receptors (FGFRs) is essential for many cellular processes including proliferation and migration as well as differentiation events such as angiogenesis, osteogenesis, and chondrogenesis. Recently, genetic screens in Drosophila and gene expression screens in zebrafish have resulted in the identification of several feedback inhibitors of FGF signaling. One of these, Sef (similar expression to fgf genes), encodes a transmembrane protein that belongs to the FGF synexpression group. Here we show that like zebrafish Sef (zSef), mouse Sef (mSef) interacts with FGFR1 and that the cytoplasmic domain of mSef mediates this interaction. Overexpression of mSef in NIH3T3 cells results in a decrease in FGF-induced cell proliferation associated with a decrease in Tyr phosphorylation of FGFR1 and FRS2. As a consequence, there is a reduction in the phosphorylation of Raf-1 at Ser(338), MEK1/2 at Ser(217) and Ser(221), and ERK1/2 at Thr(202) and Tyr(204). Furthermore, mSef inhibits ERK activation mediated by a constitutively activated FGFR1 but not by a constitutively active Ras and decreases FGF but not PDGF-mediated activation of Akt. These results indicate that Sef exerts its inhibitory effects at the level of FGFR and upstream of Ras providing an additional level of negative regulation of FGF signaling.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12604616     DOI: 10.1074/jbc.C200606200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  44 in total

Review 1.  Control of MAP kinase signaling to the nucleus.

Authors:  Kunio Kondoh; Satoru Torii; Eisuke Nishida
Journal:  Chromosoma       Date:  2005-05-18       Impact factor: 4.316

Review 2.  An essential role for FGF receptor signaling in lens development.

Authors:  Michael L Robinson
Journal:  Semin Cell Dev Biol       Date:  2006-10-27       Impact factor: 7.727

3.  Deficiency of Sef is associated with increased postnatal cortical bone mass by regulating Runx2 activity.

Authors:  Qing He; Xuehui Yang; Yan Gong; Dmitry Kovalenko; Ernesto Canalis; Clifford J Rosen; Robert E Friesel
Journal:  J Bone Miner Res       Date:  2014       Impact factor: 6.741

Review 4.  Fibroblast growth factor signaling in the vasculature.

Authors:  Xuehui Yang; Lucy Liaw; Igor Prudovsky; Peter C Brooks; Calvin Vary; Leif Oxburgh; Robert Friesel
Journal:  Curr Atheroscler Rep       Date:  2015-06       Impact factor: 5.113

5.  Sef Regulates Epithelial-Mesenchymal Transition in Breast Cancer Cells.

Authors:  Qing He; Yan Gong; Lindsey Gower; Xuehui Yang; Robert E Friesel
Journal:  J Cell Biochem       Date:  2016-03-16       Impact factor: 4.429

6.  Lrig3 regulates neural crest formation in Xenopus by modulating Fgf and Wnt signaling pathways.

Authors:  Hui Zhao; Kosuke Tanegashima; Hyunju Ro; Igor B Dawid
Journal:  Development       Date:  2008-02-20       Impact factor: 6.868

7.  Negative Regulation of Receptor Tyrosine Kinase (RTK) Signaling: A Developing Field.

Authors:  Fernanda Ledda; Gustavo Paratcha
Journal:  Biomark Insights       Date:  2007-02-14

8.  FGFR1 forms an FRS2-dependent complex with mTOR to regulate smooth muscle marker gene expression.

Authors:  Pei-Yu Chen; Robert Friesel
Journal:  Biochem Biophys Res Commun       Date:  2009-03-13       Impact factor: 3.575

9.  Similar expression to FGF (Sef) inhibits fibroblast growth factor-induced tumourigenic behaviour in prostate cancer cells and is downregulated in aggressive clinical disease.

Authors:  S Darby; T Murphy; H Thomas; C N Robson; H Y Leung; M E Mathers; V J Gnanapragasam
Journal:  Br J Cancer       Date:  2009-11-03       Impact factor: 7.640

10.  Molecular properties of CD133+ glioblastoma stem cells derived from treatment-refractory recurrent brain tumors.

Authors:  Qinghai Liu; David H Nguyen; Qinghua Dong; Peter Shitaku; Kenneth Chung; On Ying Liu; Jonathan L Tso; Jason Y Liu; Veerauo Konkankit; Timothy F Cloughesy; Paul S Mischel; Timothy F Lane; Linda M Liau; Stanley F Nelson; Cho-Lea Tso
Journal:  J Neurooncol       Date:  2009-05-26       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.